483 Response Livzon Group (Ningxia) Pharmaceutical Oct 2018

Joel Hustedt FDA$119.00 - Available Now

FDA investigators audited the Livzon Group (Ningxia) Pharmaceutical - Shizuishan, China facility and issued inspectional observation (via FDA 483) on 19 Oct 2018.

Product details

  • Category:
  • Inspection end: 19 Oct 2018
  • Location: Shizuishan, China
  • FEI: 3012375554
Add To Cart